Sympathetic ganglia consist of noradrenergic and cholinergic neurons. The cholinergic marker protein vesicular acetylcholine transporter (VAChT) and the neuropeptide vasoactive intestinal peptide (VIP), co-expressed in mature cholinergic sympathetic neurons, are ®rst detectable during embryonic development of rat sympathetic ganglia. However, the subpopulation of cholinergic sympathetic neurons which innervates sweat glands in mammalian footpads starts to express VAChT and VIP during the ®rst postnatal weeks, under the in¯uence of sweat gland-derived signals. In vitro evidence suggests that the sweat gland-derived cholinergic differentiation factor belongs to a group of neuropoietic cytokines, including LIF, CNTF and CT-1, that act through a LIFRb-containing cytokine receptor. To investigate whether the embryonic expression of cholinergic properties is elicited by a related cytokine, the expression of VAChT and VIP was analyzed in stellate ganglia of mice de®cient for the cytokine receptor subunits LIFRb or CNTFRa. The density of VAChT-and VIP-immunoreactive cells in stellate ganglia of new-born animals was not different in LIFRb 2/2 and CNTFRa 2/2 ganglia as compared to ganglia from wild-type mice. These results demonstrate that the early, embryonic expression of VAChT and VIP is not induced by cytokines acting through LIFRb-or CNTFRa-containing receptors. q
Introduction
Sympathetic ganglia of the vertebrate autonomic nervous system are composed of two major neuronal populations of mature sympathetic ganglia, noradrenergic and cholinergic neurons. The development of cholinergic sympathetic neurons is one of the best understood examples for the extrinsic control of neurotransmitter phenotype (Landis, 1990; Ernsberger and Rohrer, 1999; Francis and Landis, 1999) . Mature cholinergic sympathetic neurons are characterized by the expression of choline acetyltransferase (ChAT), VAChT, acetylcholine esterase and VIP (Landis and Keefe, 1983; Lundberg and Ho Èkfelt, 1986; Elfvin et al., 1993; Ernsberger et al., 1997; Scha Èfer et al., 1997; Guidry and Landis, 1998) . Targets for cholinergic sympathetic neurons are muscle arteries and periosteum, receiving both cholinergic and noradrenergic sympathetic innervation, and sweat glands in mammalian footpads, that are purely cholinergically innervated (Lundberg et al., 1979; Dehal et al., 1992; Schotzinger et al., 1994; Anderson et al., 1996; Francis et al., 1997; Guidry and Landis, 1998) . Sweat gland-innervating neurons differ from cholinergic, blood vessel-innervating neurons by the expression of calcitonin gene-related peptide (CGRP) and their scattered localization, as opposed to the clusters of vasomotor neurons in sympathetic ganglia (Lindh et al., 1989; Lindh and Ho Èkfelt, 1990; Gibbins, 1992; Morris et al., 1998) . In avian paravertebral ganglia cholinergic neurons are mostly clustered, express VIP, lack CGRP (New and Mudge, 1986; Ernsberger et al., 1997) and innervate arteries in skeletal muscle and skin (U. Zechbauer and H. Rohrer, unpublished data). As birds do not have sweat glands, cholinergic neurons of avian sympathetic ganglia may consist mainly, if not exclusively, of blood vessel innervating neurons.
The initial onset of VAChT and VIP expression was observed in rat sympathetic ganglia at E12 and E14, respectively (Tyrrell and Landis, 1994; Scha Èfer et al., 1997 Scha Èfer et al., , 1998 Guidry and Landis, 1998; Schu Ètz et al., 1998) . In thoracic paravertebral ganglia of chick embryos at comparable developmental stages (E6), ChAT and VAChT were detected in a large number of cells (Ernsberger et al., 1997; M. Stanke, unpublished data) . Avian sympathetic ganglia differ from mammalian ganglia by the lack of VIP expression during this early stage of ganglion development (Ernsberger et al., 1997) . The onset of ChAT and VAChT expression before the innervation of sympathetic targets suggests that the early embryonic expression of these genes is not dependent on signals from these tissues (Ernsberger and Rohrer, 1999) .
The target-dependent cholinergic differentiation was studied in most detail for sweat gland-innervating neurons. Rat sweat glands are contacted by adrenergic sympathetic ®bres at E22 and P2 in the front and hind footpads, respectively (Guidry and Landis, 1998) . Cholinergic marker proteins VAChT, ChAT and co-expressed neuropeptides VIP and CGRP are detectable in sweat gland-innervating ®bres of the rat only after target contact (Landis and Keefe, 1983; Leblanc and Landis, 1986; Landis et al., 1988; Guidry and Landis, 1998) . The cholinergic differentiation of sweat gland innervation in the mouse displayed properties and a time course similar to that in the rat (Coughlin et al., 1978; Guidry and Landis, 1995) , although the expression of ChAT, VAChT and VIP at the cellular level has not yet been analyzed. The causal role of sweat glands in cholinergic differentiation was demonstrated by transplantation of sweat gland-containing skin to regions of hairy skin, resulting in cholinergic innervation of ectopic sweat glands (Schotzinger and Landis, 1988; Schotzinger et al., 1994) .
Sweat gland homogenates contain a cholinergic differentiation activity that induces the expression of ChAT and VIP and reduces the expression of adrenergic properties in cultured sympathetic neurons (Rao and Landis, 1990; Rao et al., 1992a; Rohrer, 1992; Habecker and Landis, 1994; Habecker et al., 1995b) . Several lines of evidence argue that the sweat gland-derived factor is a member of the family of neuropoietic cytokines: (i) all family members, LIF (Yamamori et al., 1989) , CNTF (Ernsberger et al., 1989; Saadat et al., 1989) , GPA (Heller et al., 1993) , OSM (Rao et al., 1992b) and CT-1 (Habecker et al., 1995a) were found to elicit in cultured sympathetic neurons a switch in the neurotransmitter phenotype from adrenergic to cholinergic; (ii) the sweat gland-derived biological activity can be inhibited by an antibody that blocks cytokine receptor function by binding to a subunit of the cytokine receptor complex, LIFRb (Habecker et al., 1997) . LIFRb is an essential component of the receptors for LIF, CNTF, CT-1 and human (but not murine) OSM (Stahl and Yancopoulos, 1994; Mosley et al., 1996; Taga, 1996; Lindberg et al., 1998) . As LIF, CNTF, CT-1 and OSM were excluded as candidate sweat gland factors (Habecker et al., 1997) , it is assumed that an unknown member of the growth factor family is responsible for the target-dependent cholinergic differentiation of sudomotor sympathetic neurons.
In the present study we addressed the question whether the early, embryonic expression of VIP and VAChT in mammalian sympathetic neurons is mediated by a similar type of factor. Transgenic mice that lack either LIFRb (Li et al., 1995; Ware et al., 1995) or CNTFRa (DeChiara et al., 1995) die shortly after birth and thus can be used to investigate effects on embryonic VIP and ChAT expression, but not for effects during the postnatal sweat gland innervation. The present analysis of stellate ganglia of LIFRb and CNTFRa de®cient animals revealed no difference in the density of VIP-IR and VAChT-IR cells, excluding an involvement of LIFRb-interacting cytokines in the early onset of cholinergic differentiation.
Results
To investigate the role of neuropoietic cytokines for the early expression of cholinergic marker genes in sympathetic ganglia, the expression of VAChT-IR and VIP-IR was studied in the stellate ganglia of transgenic mice, lacking functional genes for LIFRb or CNTFRa. The stellate ganglion was chosen since this ganglion contains neurons innervating the sweat glands in the front footpad, and since a considerable number of VIP-IR and VAChT-IR neurons have been observed during embryonic development in this ganglion (Tyrrell and Landis, 1994; Scha Èfer et al., 1997; Schu Ètz et al., 1998) .
Stellate ganglia were dissected at E19.5 or P0 from control and LIFRb 2/2 or CNTFRa 2/2 transgenic mice, serially sectioned and stained for VIP-and VAChT-IR. A small number of postganglionic neurons positive for VAChT-IR or VIP-IR was detected in virtually every section. The expression of VIP and VAChT was quanti®ed by determining the number of VAChT-IR and VIP-IR cells and referring to areas of the corresponding ganglion sections. In sections from stellate ganglia of LIFRb 2/2 and CNTFRa 2/2 transgenic animals the density of VIP-IR and VAChT-IR cells was not reduced, as compared to heterozygous or wild-type controls (Fig. 1) . The mean ganglion section areas were not signi®cantly different between controls and LIFRb 2/2 or CNTFRa 2/2 mutant ganglia (1.16^0.08 and 1.110 .12 mm 2 , mean^SEM, n 9 for controls and n 3 for LIFRb 2/2 ; 1.08^0.09 and 0.99^0.12 mm 2 , meanŜ EM, n 8 for both controls and CNTFRa
2/2
). Thus, CNTFRa-and LIFRb-mediated cytokine signalling seems not to be required for the early, embryonic expression of VIP and VAChT in sympathetic ganglia.
The quanti®cation indicates that VIP-IR and VAChT-IR cells are present at comparable densities (Fig. 1) . This suggests that VIP and VAChT may be co-expressed in this small subpopulation of sympathetic neurons. Doubleimmunostainings revealed that VAChT and VIP indeed are co-expressed in the perikarya of the same cells (Fig. 2) . In addition, preganglionic axons and terminals were strongly stained by the anti-VAChT antibody ( Fig. 2A) .
Discussion
The expression of cholinergic properties during sympathetic ganglion development is initiated over a large part of development, including the period before, as well as after innervation of target tissues (Ernsberger and Rohrer, 1999) . There is convincing evidence from in vitro and in vivo studies that implies neuropoietic cytokines as signals responsible for target-dependent differentiation of cholinergic sympathetic neurons (Habecker et al., 1997; Geissen et al., 1998) . In contrast, neuropoietic cytokines acting through LIFRb or CNTFRa are not involved in the early, embryonic phase of cholinergic differentiation as demonstrated in the present study by the completely normal expression of VAChT and VIP in sympathetic ganglia of LIFRb 2/2 and CNTFRa 2/2 mice. The number of VIP-IR and VAChT-IR sympathetic neurons in P0 and adult rat stellate ganglia was previously determined to be in the range of 3±5% of the neuron population (Landis and Fredieu, 1986; Tyrrell and Landis, 1994; Scha Èfer et al., 1997 Scha Èfer et al., , 1998 Schu Ètz et al., 1998) . The present analysis in the mouse also revealed that only a small proportion of the total ganglion cell population expresses VIP and VAChT at birth. VIP and VAChT are co-expressed, which explains the similar density of VIP-IR and VAChT-IR cells.
Ganglia from transgenic CNTFRa 2/2 animals displayed the same density of VAChT-IR and VIP-IR neurons as wildtype control ganglia. The mean area/section is not affected in CNTFRa 2/2 animals, which is in agreement with previous observations (DeChiara et al., 1995) . This result excludes a role of CNTF in the early expression of cholinergic properties. The existence of an additional CNTF-like, Fig. 2 . Double-immunohistochemical staining for VAChT and VIP in the mouse stellate ganglion. Frozen sections from P0 mouse stellate ganglia were sequentially stained with rabbit antisera against VAChT and sheep antisera against VIP, followed by Alexa 594-labeled anti-rabbit and Alexa 488-labeled antisheep secondary antibodies. VAChT-staining (red) (A) and VIP-staining (green) (B) and overlay (C) reveal co-expression in sympathetic neurons but not in preganglionic innervation. Arrows in (A) indicate VAChT-IR preganglionic terminals and axons. Bar 20 mm. CNTFRa-binding factor that is embryonically expressed has been deduced from the observation that CNTFRa 2/2 mice display neuronal losses not observed in CNTF 2/2 animals (DeChiara et al., 1995). The present ®ndings exclude an involvement of this factor in cholinergic differentiation of embryonic sympathetic neurons.
The elimination of LIFRb in LIFRb 2/2 animals does not affect the density of VIP-IR and VAChT-IR cells. We did not observe effects on the mean section area, suggesting that LIF-related cytokines have no major effect on embryonic sympathetic neuron survival. The persistent expression of VIP and VAChT in LIFRb 2/2 mice excludes LIF, CT-1, CNTF and related (unknown) factors, acting through LIFRb-containing receptors, as candidates for embryonic cholinergic differentiation factors. Whereas the cholinergic differentiation factor(s) present in sweat gland homogenates act(s) through LIFRb (Habecker et al., 1997) , LIFRbcontaining cytokine receptors are not involved in the early expression of VAChT and VIP. The present data do not exclude the involvement of cytokines acting through receptors that do not contain LIFRb, cf. IL-6 and mOSM. The receptors for IL-6 and mOSM use gp130 homodimers or a heterodimer between gp130 and an OSMRb as signal transducing subunits (Mosley et al., 1996; Taga, 1996; Lindberg et al., 1998) . Using an antisense RNA strategy, it was demonstrated in chick sympathetic ganglia, that cytokines acting through gp130 are not involved in the early, targetindependent ChAT expression (Geissen et al., 1998) . Taken together, these results suggest that the early onset of VAChT and VIP expression in embryonic mammalian sympathetic ganglia, and the expression of ChAT in avian sympathetic ganglia are initiated by similar mechanisms that do not involve neuropoietic cytokines.
The relationship between neurons expressing cholinergic markers during early, embryonic stages and cells that express cholinergic proteins after target contact postnatally is presently unclear. The simplest interpretation is that different mechanisms of cholinergic differentiation are active in vasomotor and sudomotor sympathetic neurons. Whereas the sweat-gland-innervating neurons acquire cholinergic properties only after target contact, neurons expressing VAChT and VIP during embryonic development may represent blood vessel-innervating neurons that would start to express these genes before target contact (Ernsberger and Rohrer, 1999) . In conclusion, these results suggest a complex control of cholinergic sympathetic differentiation that may vary for different neuronal subpopulations.
Experimental procedures

Materials and animals
Rabbit antiserum 80259 raised against the C-terminal peptide CEDDDYNYYSRS of rat VAChT (Scha Èfer et al., 1998) was a kind gift of Lee Eiden, NIMH, Bethesda, MD.
Rabbit antiserum against pVIP was purchased from Incstar, Stillwater, Minnesota, MN through Sorin Diagnostica, Du Èsseldorf. CNTFRa 1/2 transgenic mice (DeChiara et al., 1995) were a generous gift from G. Yancopoulos and T. DeChiara, Regeneron Pharmaceuticals, Tarrytown, NY. LIFRb 1/2 transgenic animals (Li et al., 1995) were generously provided by Austin Smith (Centre for Genome Research, University of Edinburgh, UK) through Michael Sendtner (University of Wu Èrzburg, Germany).
Tissue preparation
Stellate ganglia were dissected from litters of heterozygous crossings of either CNTFRa 1/2 or LIFRb 1/2 animals at P0.5 or E19.5, respectively. The genotype of the animals was determined by southern blotting as described previously (DeChiara et al., 1995; Li et al., 1995) . The ganglia were ®xed for 2 h at 48C in 4% paraformaldehyde in 0.1 M sodium phosphate buffer (pH 7.0). After ®xation, the tissues were immersed overnight in 15% sucrose (in 0.1 M sodium phosphate buffer, pH 7.0) and embedded in Tissue Tek (Sakura Fintek Europe BV, Zoeterwoude, Netherlands). The whole ganglion was sectioned and consecutive 10 mm cryostat cross-sections were collected on alternate gelatincoated glass slides and stored at 2808C.
Immunohistochemistry
Sections were equilibrated at room temperature and blocked for 1 h with buffer 1 (PBS supplemented with 1.7% NaCl and 0.2% Triton X-100) containing 10% donkey serum. The sections were washed and then incubated overnight at room temperature (RT) with rabbit antibodies against VIP (1:100) or VAChT (1:2000) , diluted in buffer 1. After washing with PBS (three times for 15 min each) Cy3-coupled anti-rabbit Ig antibody was added for 2 h at RT. After three additional washing steps (twice with buffer 1, once with PBS) the sections were mounted in PBS± glycerol (50%; v/v) and analyzed by¯uorescence microscopy. The number of VIP-IR and VAChT-IR cells was counted on all sections of all ganglia. The area of sympathetic ganglion sections was acquired by confocal microscopy (Sarrastro 2000, Molecular Dynamics) and analyzed with a Silicon Graphics Workstation running the Image Space software program (Version 3.10, Molecular Dynamics). The analysis of VIP/VAChT cell numbers and the area measurements were carried out with coded slides, i.e. without knowing the genotype of the ganglia analyzed. Data were analyzed for the signi®cance of differences in areas or VIP/VAChT neuron numbers between mutant and control mice using t-test, ANOVA and Wilcoxon test. Double-staining of VIP and VAChT was carried out by sequential staining with rabbit anti-VAChT, sheep anti-VIP (Chemicon, Temecula, CA), followed by Alexa 594-coupled anti-rabbit Ig antibody and Alexa 488-coupled antisheep Ig antibody (Molecular Probes, Eugene, OR).
